Anti-Sumo 2 + Sumo 3 antibody [8A2] (ab81371) is a mouse monoclonal antibody detecting Sumo 2 + Sumo 3 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- Over 60 publications
- Trusted since 2009
View Alternative Names
SMT3B, SMT3H2, SUMO2, Small ubiquitin-related modifier 2, SUMO-2, HSMT3, SMT3 homolog 2, SUMO-3, Sentrin-2, Ubiquitin-like protein SMT3B, Smt3B, SMT3A, SMT3H1, SUMO3, Small ubiquitin-related modifier 3, SUMO-3, SMT3 homolog 1, SUMO-2, Ubiquitin-like protein SMT3A, Smt3A
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Immunocytochemistry/immunofluorescence analysis of HeLa cells labelling Sumo 2 + Sumo 3 with ab81371 at 1/50 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Primary antibody, ab81371 at 1 : 50 was incubated overnight at 4° C, followed by AlexaFluor® 488-conjugated Goat anti- Mouse secondary antibody (ab150113) at 1/1000 dilution at RT for 45 min. ab179513 Anti-beta Tubulin, used as a counterstain at 1/200 dilution, was co-incubated with ab81371 overnight at 4° C, followed by Alexa Fluor® 594 Goat Anti-Rabbit. secondary (ab150080) at 1/1000 dilution at RT for 45 min. Nucleus were visualized using DAPI.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Immunocytochemistry/immunofluorescence analysis of SW480 cell line labelling Sumo 2 + Sumo 3 with ab81371 at 1/50 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Primary antibody, ab81371 at 1 : 50 was incubated overnight at 4° C, followed by AlexaFluor® 488-conjugated Goat anti- Mouse secondary antibody (ab150113) at 1/1000 dilution at RT for 45 min. ab179513 Anti-beta Tubulin, used as a counterstain at 1/200 dilution, was co-incubated with ab81371 overnight at 4° C, followed by Alexa Fluor® 594 Goat Anti-Rabbit. secondary (ab150080) at 1/1000 dilution at RT for 45 min. Nucleus were visualized using DAPI.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue labeling Sumo 2 + Sumo 3 with ab81371 at 1/1000 dilution followed by a ready to use Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879). The section was incubated with ab81371 for overnight at 4℃.
Secondary antibody only control : Ready to use Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879).
Heat mediated antigen retrieval with citrate buffer (pH 6.0, epitope retrieval solution1).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Immunocytochemistry/immunofluorescence analysis of NIH/3T3 cells labelling Sumo 2 + Sumo 3 with ab81371 at 1/50 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Primary antibody, ab81371 at 1 : 50 was incubated overnight at 4° C, followed by AlexaFluor® 488-conjugated Goat anti- Mouse secondary antibody (ab150113) at 1/1000 dilution at RT for 45 min. ab179513 Anti-beta Tubulin, used as a counterstain at 1/200 dilution, was co-incubated with ab81371 overnight at 4° C, followed by Alexa Fluor® 594 Goat Anti-Rabbit. secondary (ab150080) at 1/1000 dilution at RT for 45 min. Nucleus were visualized using DAPI.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Immunohistochemical analysis of paraffin-embedded rat kidney tissue labeling Sumo 2 + Sumo 3 with ab81371 at 1/1000 dilution followed by a ready to use Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879). The section was incubated with ab81371 for overnight at 4℃.
Secondary antibody only control : Ready to use Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879).
Heat mediated antigen retrieval with citrate buffer (pH 6.0, epitope retrieval solution1).
- WB
Lab
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (ab81371) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate B276 at 10 µg
Lane 2:
SH-SY5Y (human neuroblastoma epithelial cell), whole cell lysate at 10 µg
Lane 3:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 10 µg
Lane 4:
SW480 (human colorectal adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 5:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 10 µg
Lane 6:
293T (human embryonic kidney epithelial cell), whole cell lysate at 10 µg
Lane 7:
PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 10 µg
Lane 8:
NIH/3T3 (mouse embryonic fibroblast), whole cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Predicted band size: 12 kDa
Observed band size: 15 kDa
false
- WB
Unknown
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Dilution and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (ab81371) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 10 µg
Lane 2:
Human kidney tissue lysate at 10 µg
Lane 3:
Human spleen tissue lysate at 10 µg
Lane 4:
Mouse brain tissue lysate at 10 µg
Lane 5:
Rat spleen tissue lysate at 10 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Predicted band size: 12 kDa
Observed band size: 15 kDa
false
- WB
CiteAb
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Western Blotting using Anti-Sumo 2 + Sumo 3 antibody [8A2], ab81371. Publication image from Eifler, K. et al., 2018, Nat Commun, 29549242. Legend direct from paper.
Knockdown of the SUMO conjugation pathway delays transition through mitosis and induces the formation of chromosome bridges. a Knockdown of the SUMO-activating enzyme (SAE) in HeLa cells was achieved by stably expressing inducible shRNAs generated against both SAE subunits SAE1 (ishSAE1) and SAE2 (ishSAE2.1 and ishSAE2.2). Scrambled shRNA was used as a control (ishControl). These cells were analyzed by live cell microscopy 48 h after induction of the SAE knockdown. Pictures were acquired every 5 min and a selection of pictures is depicted here. Scale bars correspond to 10 µM. b The amount of time needed for cells to pass from nuclear envelope breakdown (NEB) to metaphase (dark grey) and from metaphase to anaphase (light grey) was quantified by live cell imaging. Standard deviations were calculated for >200 cells resulting from three independent experiments. A two-sided Student’s t-test was performed. *p-values < 0.05. c To confirm a reduction of SUMO conjugates and SAE2 expression, lysates of HeLa cells expressing inducible SAE knockdown constructs were analyzed by immunoblotting with anti-SUMO2/3 and anti-SAE2 antibody 48 h after induction and compared to the control. Equal loading of the lysates was verified by staining with Ponceau S. d HeLa cells expressing inducible SAE knockdown constructs were fixed 72 h after induction and stained with Hoechst to monitor the formation of chromosome bridges (white arrows). Scale bars correspond to 10 µM. e The percentage of cells with DNA bridges 72 h after induction of SAE knockdown was quantified using the microscopy approach described above, analyzing 100 cells per condition. The standard error of the mean was calculated from three independent experiments. A two-sided Student’s t-test was performed. *p-values < 0.005
false
- WB
CiteAb
Western blot - Anti-Sumo 2 + Sumo 3 antibody [8A2] (AB81371)
Western Blotting using Anti-Sumo 2 + Sumo 3 antibody [8A2], ab81371. Publication image from Eifler, K. et al., 2018, Nat Commun, 29549242. Legend direct from paper.
Posttranslational modification of the APC/C by SUMOylation. a Alignment of the Cullin domains present in the human Cullin proteins and the Cullin-like domain of APC2 : The NEDDylated lysine residue within the Cullin proteins is highlighted in red and is absent in APC2. b HeLa cells were treated with DMSO as a negative control (−) or 1 µM MLN4924 (+), an inhibitor of the NEDD8-activating enzyme, for 16 h. Lysates were analyzed by immunoblotting with anti-APC2 and anti-CUL4A antibodies. Ponceau S staining was performed to monitor equal loading. c HeLa cells and HeLa cells expressing His-tagged SUMO2 (His-SUMO2) were subjected to a His-pulldown (His-PD). Input and pulldown samples were analyzed by immunoblotting making use of anti-APC4 and anti-SUMO2/3 antibodies. Blots were stained with Ponceau S to monitor equal loading. At least three independent experiments were performed and representative results are shown
false
Related conjugates and formulations (1)
-
Anti-Sumo 2 + Sumo 3 antibody [8A2] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-Sumo 2 + Sumo 3 antibody [8A2] (ab81371) is a mouse recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of Sumo 2 + Sumo 3?
Anti-Sumo 2 + Sumo 3 [8A2] (ab81371) specifically detects a band for Sumo 2 + Sumo 3 (UniProt: P61956) at a molecular weight of 12kDa.
Trusted by the scientific community
Anti-Sumo 2 + Sumo 3 [8A2] (ab81371) was first used in a scientific publication in 2009 and has been cited over 60 times in peer-reviewed journals.
Reviewed by scientists
Anti-Sumo 2 + Sumo 3 [8A2] (ab81371) has over 5 independent reviews from customers.
Other related products
We have a range of other formats of antibody clone [8A2] also available for your convenience: ab81371, Carrier free - ab252805
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Sumo 2 and Sumo 3 play essential roles in numerous cellular processes by modifying several target proteins in the nucleus and cytoplasm. They are part of a complex regulatory system that modulates processes like nuclear transport chromosome segregation and DNA repair. Sumo 2/3 often work in tandem with other members of the SUMO family including SUMO-1 to ensure proper cellular homeostasis.
Pathways
Sumo 2 and Sumo 3 are intimately involved in fundamental cellular signaling pathways such as the p53 pathway and NF-κB pathway. These proteins modulate the activity of key proteins within these pathways including the tumor suppressor p53 and the transcription factor NF-κB which regulate cell survival proliferation and apoptosis. Sumo 2/3-related modifications can alter the stability and function of these proteins thereby influencing cellular response to stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (84)
Recent publications for all applications. Explore the full list and refine your search
Nucleic acids research 53: PubMed40744492
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6261 PubMed40623999
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1577781 PubMed40534859
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 15:6369-6386 PubMed40521184
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:230 PubMed40348773
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed39937027
2025
Applications
Unspecified application
Species
Unspecified reactive species
Organogenesis 21:2460269 PubMed39905673
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107319 PubMed38677512
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature structural & molecular biology 31:1355-1367 PubMed38649616
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature microbiology 9:988-1006 PubMed38538832
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com